- 1、本文档共31页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
活血汤治疗咳嗽变的异性哮喘临床观察
Clinical Observation of Shu Feng Huo Xue Decoction in the
Treatment of Cough Variant Asthma
Speciality: Chinese Medicine Clinical Respiratory Medicine Professional
Author:Sun guoming
Tutor:Professor Zhang Weilu
Abstract
Object: This study was to investigate integrative Medicine of cough variant asthma
(CVA) effective for clinical treatment of CVA to provide new ideas and methods.
Method: 60 patients were divided into test group of 30 and control group of 30. Test
group received the standard treatment in shu feng huo xue decoction and Pulmicort
Turbuhaler.Control group received Pulmicort Turbuhaler only.
Results: After treatment, the condition changes, clinical efficacy was observed after
treatment, improvement of symptoms, symptom scores improved, PEF, FEF mutation rate,
FEV1 improved other aspects of the results and statistical analysis, the difference was
statistically significant (p0.05 ); that the clinical effect of the observation group compared
with the control group, there were significant differences.
Conclusion: Shufeng Decoction combined with western medicine inhaled
corticosteroid Pulmicort Turbuhaler (budesonide inhalation powder) for the clinical
treatment of CVA, improve or eliminate the symptoms quickly, control the acute onset and
duration of high cure rate, relieve pain, the effect significantly, no significant side effects.
Key words
cough variant asthma; shu feng huo xue decoction; syndrome of
intermingled phlegm and blood stasis; combination of Chinese traditional and western
medicin
目
录
引
言 ............................................................................................................................... 1
临床研究 ............................................................................................................................... 2
一、临床资料 ....................................................................................................................... 2
(一)病例来源与分组 ...........................................
您可能关注的文档
最近下载
- 矽力杰产品规格书SY5055.pdf VIP
- 道闸项目报价清单.xlsx VIP
- 贵州省预防接种技能竞赛理论考试题库资料(含答案).pdf VIP
- AASHTO-LRFD-SI-2007(4)桥梁手册第四章中文版.doc VIP
- AASHTO LRFD Bridge Design Specifications(AASHTO LRFD桥梁设计规范).docx VIP
- 迅达常用备件识别号查询手册_Ae5.pdf VIP
- 数学学科业务工作报告.pdf VIP
- 2023年春学期人教版初中物理九年级下册教学进度表.docx VIP
- 基于AASHTO沥青混凝土路面设计方法的应用与研究.doc VIP
- 小班科学方方和圆圆教案反思.docx VIP
文档评论(0)